News
Patients will have 24/7 access to personalized speech, language and cognitive therapies.
The company will use the funds to augment key content partnerships.
Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.
The company will use the funds to move into the female health space and increase screening and preventive care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.
AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.